Oct4 Maintains the Pluripotency of Human Embryonic Stem Cells by Inactivating P53 Through Sirt1-mediated Deacetylation

Overview

Journal Stem Cells

Publisher Oxford University Press

Specialties Cell Biology
Reproductive Medicine

Date 2013 Sep 17

PMID 24038750

Citations 65

Authors

Zhen-Ning Zhang

Sun-Ku Chung

Zheng Xu

Yang Xu

Affiliations

Soon will be listed here.

Abstract

Oct4 is critical to maintain the pluripotency of human embryonic stem cells (hESCs); however, the underlying mechanism remains to be fully understood. Here, we report that silencing of Oct4 in hESCs leads to the activation of tumor suppressor p53, inducing the differentiation of hESCs since acute disruption of p53 in p53 conditional knockout (p53CKO) hESCs prevents the differentiation of hESCs after Oct4 depletion. We further discovered that the silencing of Oct4 significantly reduces the expression of Sirt1, a deacetylase known to inhibit p53 activity and the differentiation of ESCs, leading to increased acetylation of p53 at lysine 120 and 164. The importance of Sirt1 in mediating Oct4-dependent pluripotency is revealed by the finding that the ectopic expression of Sirt1 in Oct4-silenced hESCs prevents p53 activation and hESC differentiation. In addition, using knock-in approach, we revealed that the acetylation of p53 at lysine 120 and 164 is required for both stabilization and activity of p53 in hESCs. In summary, our findings reveal a novel role of Oct4 in maintaining the pluripotency of hESCs by suppressing pathways that induce differentiation. Considering that p53 suppresses pluripotency after DNA damage response in ESCs, our findings further underscore the stringent mechanism to coordinate DNA damage response pathways and pluripotency pathways in order to maintain the pluripotency and genomic stability of hESCs.

Citing Articles

Diabetic microenvironment deteriorates the regenerative capacities of adipose mesenchymal stromal cells.

Ahmed S, Elkhenany H, Ahmed T, Ghoneim N, Elkodous M, Mohamed R Diabetol Metab Syndr. 2024; 16(1):131.

PMID: 38880916 PMC: 11181634. DOI: 10.1186/s13098-024-01365-1.

Vascular architecture regulates mesenchymal stromal cell heterogeneity via P53-PDGF signaling in the mouse incisor.

Guo T, Pei F, Zhang M, Yamada T, Feng J, Jing J Cell Stem Cell. 2024; 31(6):904-920.e6.

PMID: 38703771 PMC: 11162319. DOI: 10.1016/j.stem.2024.04.011.

P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition.

Valverde-Lopez J, Li-Bao L, Sierra R, Santos E, Giovinazzo G, Diaz-Diaz C PLoS Genet. 2024; 20(3):e1011193.

PMID: 38489392 PMC: 10971546. DOI: 10.1371/journal.pgen.1011193.

Sirtuins Affect Cancer Stem Cells via Epigenetic Regulation of Autophagy.

Sipos F, Muzes G Biomedicines. 2024; 12(2).

PMID: 38397988 PMC: 10886574. DOI: 10.3390/biomedicines12020386.

The SIRT1-c-Myc axis in regulation of stem cells.

Fan W, Li X Front Cell Dev Biol. 2023; 11:1236968.

PMID: 37554307 PMC: 10405831. DOI: 10.3389/fcell.2023.1236968.

References

Marion R, Strati K, Li H, Murga M, Blanco R, Ortega S . A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature. 2009; 460(7259):1149-53. PMC: 3624089. DOI: 10.1038/nature08287. View

Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park S . SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell. 2008; 135(5):907-18. PMC: 2853975. DOI: 10.1016/j.cell.2008.10.025. View

Tang Y, Luo J, Zhang W, Gu W . Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell. 2006; 24(6):827-39. DOI: 10.1016/j.molcel.2006.11.021. View

Utikal J, Polo J, Stadtfeld M, Maherali N, Kulalert W, Walsh R . Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature. 2009; 460(7259):1145-8. PMC: 3987892. DOI: 10.1038/nature08285. View

Vousden K, Prives C . Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3):413-31. DOI: 10.1016/j.cell.2009.04.037. View

Tang Y, Zhao W, Chen Y, Zhao Y, Gu W . Acetylation is indispensable for p53 activation. Cell. 2008; 133(4):612-26. PMC: 2914560. DOI: 10.1016/j.cell.2008.03.025. View

Lister R, Pelizzola M, Dowen R, Hawkins R, Hon G, Tonti-Filippini J . Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009; 462(7271):315-22. PMC: 2857523. DOI: 10.1038/nature08514. View

Won K, Xu Z, Zhang X, Whitaker J, Shoemaker R, Ren B . Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cells. Nucleic Acids Res. 2012; 40(17):8199-209. PMC: 3458541. DOI: 10.1093/nar/gks584. View

Chen X, Xu H, Yuan P, Fang F, Huss M, Vega V . Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008; 133(6):1106-17. DOI: 10.1016/j.cell.2008.04.043. View

10.

Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y . Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 2012; 149(6):1269-83. PMC: 3688046. DOI: 10.1016/j.cell.2012.04.026. View

11.

Jain A, Allton K, Iacovino M, Mahen E, Milczarek R, Zwaka T . p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol. 2012; 10(2):e1001268. PMC: 3289600. DOI: 10.1371/journal.pbio.1001268. View

12.

Dawud R, Schreiber K, Schomburg D, Adjaye J . Human embryonic stem cells and embryonal carcinoma cells have overlapping and distinct metabolic signatures. PLoS One. 2012; 7(6):e39896. PMC: 3387229. DOI: 10.1371/journal.pone.0039896. View

13.

Rehman J . Empowering self-renewal and differentiation: the role of mitochondria in stem cells. J Mol Med (Berl). 2010; 88(10):981-6. PMC: 3006229. DOI: 10.1007/s00109-010-0678-2. View

14.

Remenyi A, Lins K, Nissen L, Reinbold R, Scholer H, Wilmanns M . Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev. 2003; 17(16):2048-59. PMC: 196258. DOI: 10.1101/gad.269303. View

15.

Liu D, Ou L, Clemenson Jr G, Chao C, Lutske M, Zambetti G . Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol. 2010; 12(10):993-8. PMC: 3025300. DOI: 10.1038/ncb2100. View

16.

Blander G, Guarente L . The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004; 73:417-35. DOI: 10.1146/annurev.biochem.73.011303.073651. View

17.

Kawamura T, Suzuki J, Wang Y, Menendez S, Morera L, Raya A . Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 2009; 460(7259):1140-4. PMC: 2735889. DOI: 10.1038/nature08311. View

18.

Brooks C, Gu W . New insights into p53 activation. Cell Res. 2010; 20(6):614-21. PMC: 3070262. DOI: 10.1038/cr.2010.53. View

19.

Hochedlinger K, Yamada Y, Beard C, Jaenisch R . Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 2005; 121(3):465-77. DOI: 10.1016/j.cell.2005.02.018. View

20.

Vaziri H, Dessain S, Ng Eaton E, Imai S, Frye R, Pandita T . hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001; 107(2):149-59. DOI: 10.1016/s0092-8674(01)00527-x. View